Skip to main content
UniHealth

Doctor search

Amarpali Brar, MD

Nephrology · San Francisco

NPI 1104001718

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
9
1 carrier
Offices
6
Since medical school
23 years
Graduated 2003

Offices

6 locations · UCSF Medical Group Business Services · 1,533 clinicians in this group

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

9 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence C154027 · Current

Licensed to practise in California · since 2018 · expires 2027-11-30 · Baba Farid University of Health Sciences Government Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Nephrology

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$72,135

Medicare paid this office $72,135 for 283 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)145$36,183$117
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes52$9,610$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes24$6,995$104
New patient visit (60+ min)26$3,852$148
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's131$3,517$14
See all 8 services
Every Original Medicare service billed
Long return visit (40+ min)145$36,183$117
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes52$9,610$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes24$6,995$104
New patient visit (60+ min)26$3,852$148
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's131$3,517$14
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes28$3,337$115
Telephone medical discussion with physician, 21-30 minutes29$3,208$75
Return visit (30+ min)11$950$86

Who their Medicare patients are

283 Original Medicare patients in 2024. Average age 61 · Under 65 48% · Women 44% · Also on Medicaid 62% · Health risk score 4.97. Above the middle of the specialty; the typical nephrology clinician is at 4.01.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 65% · Coronary heart disease 41% · Heart failure 36% · Atrial fibrillation 25% · Depression 23% · Cancer 11% · COPD 10% · Stroke 9% · Dementia 5%.

The office billed $440,712, Medicare allowed $96,283 and paid $72,135; for 929 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024283929614.97$440,712$72,135
2023370930595.48$606,263$99,407
2022295782604.49$502,859$82,178
2021260676594.61$437,522$73,976
2020277595585.07$376,293$54,915
2019287416595.84$162,984$33,000
2018280503586.63$143,484$36,675
2017404774597.39$229,868$56,580
2016417692587.08$215,046$55,453
2015471908586.83$271,745$74,798
20145141,182586.42$358,038$93,655
20134611,013576.79$295,539$85,604

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Long return visit (40+ min)165$45,015$120
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes64$19,609$102
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes54$7,015$68
New patient visit (60+ min)44$6,422$146
Initial hospital care with moderate level of medical decision making at least 75 minutes37$5,390$142
Telephone medical discussion with physician, 21-30 minutes30$3,453$80
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes29$3,309$114
Long return visit (40+ min)13$1,972$141
Hospital discharge day management, more than 30 minutes15$1,544$103
Return visit (30+ min)15$1,389$87

2022: 8 services

Original Medicare services billed in 2022
Long return visit (40+ min)135$36,131$117
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes70$21,736$90
Initial hospital care with moderate level of medical decision making at least 75 minutes30$5,227$174
Telephone medical discussion with physician, 21-30 minutes35$4,195$81
New patient visit (60+ min)26$4,081$157
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes13$1,538$118
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes16$1,482$82
Telephone medical discussion with physician, 21-30 minutes11$1,295$108

2021: 7 services

Original Medicare services billed in 2021
Long return visit (40+ min)147$42,531$125
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$11,749$94
Dialysis procedure including 1 evaluation21$5,385$80
New patient visit (60+ min)25$3,650$146
Telephone medical discussion with physician, 21-30 minutes26$3,340$74
Initial hospital care with moderate level of medical decision making at least 75 minutes13$2,368$182
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes13$1,362$91

2020: 7 services

Original Medicare services billed in 2020
Long return visit (40+ min)137$18,467$93
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes56$15,233$96
Return visit (30+ min)57$5,842$71
Initial hospital care with moderate level of medical decision making at least 75 minutes14$2,591$185
New patient visit (60+ min)18$2,472$137
Telephone medical discussion with physician, 21-30 minutes26$2,189$71
New patient visit (45+ min)15$1,690$113

2019: 7 services

Original Medicare services billed in 2019
Long return visit (40+ min)78$8,027$98
Return visit (30+ min)100$7,722$70
Hemodialysis procedure with physician evaluation46$5,416$66
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes22$3,831$66
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes30$3,750$125
New patient visit (45+ min)16$1,893$118
Short return visit (20+ min)27$1,329$46

2018: 5 services

Original Medicare services billed in 2018
Return visit (30+ min)162$13,903$66
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes42$8,212$61
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes39$5,168$120
New patient visit (45+ min)44$4,733$108
Hemodialysis procedure with physician evaluation40$2,942$61

2017: 7 services

Original Medicare services billed in 2017
Return visit (30+ min)177$13,500$65
Hemodialysis procedure with physician evaluation89$10,651$61
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes60$9,717$62
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes66$8,954$118
Long return visit (40+ min)84$7,505$86
New patient visit (45+ min)44$4,428$101
Short return visit (20+ min)14$611$44

2016: 7 services

Original Medicare services billed in 2016
Long return visit (40+ min)236$22,538$94
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes72$10,936$62
Hemodialysis procedure with physician evaluation74$7,748$62
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes35$4,201$120
Return visit (30+ min)50$4,118$65
New patient visit (45+ min)29$3,217$111
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$1,267$91

2015: 8 services

Original Medicare services billed in 2015
Long return visit (40+ min)161$16,746$101
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes68$14,213$65
Return visit (30+ min)149$11,892$68
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes49$9,432$93
Hemodialysis procedure with physician evaluation68$6,740$65
New patient visit (45+ min)47$5,509$117
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes49$5,350$94
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes27$3,520$126

2014: 8 services

Original Medicare services billed in 2014
Long return visit (40+ min)205$20,776$96
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes97$18,397$62
Return visit (30+ min)142$11,611$68
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes39$10,787$90
Hemodialysis procedure with physician evaluation68$10,466$63
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes86$9,373$89
New patient visit (45+ min)49$5,659$115
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes42$5,196$118

2013: 8 services

Original Medicare services billed in 2013
Return visit (30+ min)244$29,273$93
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes84$22,047$62
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes75$10,452$119
Long return visit (40+ min)58$7,177$122
New patient visit (45+ min)46$6,450$140
Hemodialysis procedure with physician evaluation62$5,807$62
Long return visit (40+ min)16$1,507$94
Return visit (30+ min)12$869$67

Medicaid work

$27,921 in 2024

Medicaid paid $27,921 for 293 billed services this clinician did in 2024, up to 39 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)223$24,675
New patient visit (60+ min)12$2,772
Telehealth transmission, per minute, professional services bill separately58$474
Medicaid work by year
2024293339$27,921
2023639542$42,910
2022597537$37,702
2021291430$18,957
2020140424$7,347
201980228$2,641
201866118$230
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)384$34,755
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES70$4,796
Telehealth originating site facility fee47$2,009
Telehealth transmission, per minute, professional services bill separately126$1,129
Measurement of magnesium12$221

2022

Largest Medicaid services in 2022
Long return visit (40+ min)332$29,182
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES72$4,658
Telehealth originating site facility fee81$2,972
Telehealth transmission, per minute, professional services bill separately98$764
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion14$126

2021

Largest Medicaid services in 2021
Long return visit (40+ min)209$18,126
Telehealth originating site facility fee52$581
Measurement of magnesium15$147
Phosphorus inorganic (phosphate)15$103

2020

Largest Medicaid services in 2020
Long return visit (40+ min)97$6,549
Return visit (30+ min)19$758
Hospital outpatient clinic visit for assessment and management of a patient12$40
Telehealth originating site facility fee12$0

2019

Largest Medicaid services in 2019
Long return visit (40+ min)38$2,482
Return visit (30+ min)42$159

2018

Largest Medicaid services in 2018
Return visit (30+ min)66$230

Drugs they prescribed that Part D paid

$171,389

Pharmacies billed $171,389 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,364) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.

1,172 generic and 143 brand-name prescriptions · $171,389 in drug cost · 133 antibiotic prescriptions to 61 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lokelma32$34,087$1,065
Valganciclovir62$18,430$297
Everolimus13$18,041$1,388
Envarsus Xr12$17,463$1,455
Cinacalcet34$16,126$474
See all 32 drugs
Every Part D drug this clinician prescribed
Lokelma32$34,087$1,065
Valganciclovir62$18,430$297
Everolimus13$18,041$1,388
Envarsus Xr12$17,463$1,455
Cinacalcet34$16,126$474
Tacrolimus60$10,422$174
Mycophenolate Mofetil37$6,598$178
Mycophenolic Acid16$5,491$343
Humalog Kwikpen U-10018$2,838$158
Prednisone244$1,459$6
Methenamine Hippurate13$1,398$108
Nano 2nd Gen Pen Needle16$1,202$75
Ultra-Fine Nano Pen Needle17$1,099$65
Lantus Solostar11$943$86
Nifedipine Er19$804$42
Entecavir28$541$19
Hydralazine26$492$19
Sulfamethoxazole-Trimethoprim91$453$5
Calcitriol33$439$13
Omeprazole53$369$7
Tamsulosin27$262$10
Potassium Chloride11$259$24
Amlodipine Besylate57$173$3
Fluconazole23$126$5
Carvedilol30$116$4
Losartan50$113$2
Pantoprazole11$96$9
Lisinopril20$88$4
Ciprofloxacin17$65$4
Furosemide15$58$4
Famotidine14$49$3
Rosuvastatin11$19$2

Year by year

Part D prescribing by year
20241,3642590% (0)10%$171,389
20231,685326None9%$232,114
20221,8553370% (0)8%$287,744
20212,053348None11%$346,291
20201,292288None12%$257,591
2019383810% (0)13%$26,392
2018479470% (0)19%$42,838
201728840NoneNone$50,711
201625531None25%$25,414
201535933None19%$24,145
201448442None27%$41,126
201392651None30%$105,515

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 35 drugs

Part D drugs prescribed in 2023
Cinacalcet49$35,562$726
Valganciclovir85$26,758$315
Tacrolimus94$21,696$231
Envarsus Xr28$20,618$736
Lokelma15$14,590$973
Novolog Flexpen16$10,971$686
Atovaquone12$8,816$735
Mycophenolic Acid25$6,273$251
Entecavir48$5,070$106
Humalog Kwikpen U-10014$4,431$316
Mycophenolate Mofetil47$3,638$77
Nano 2nd Gen Pen Needle18$3,082$171
Prednisone327$2,240$7
Nifedipine Er13$2,124$163
Methenamine Hippurate15$2,065$138
Losartan59$1,359$23
Sulfamethoxazole-Trimethoprim109$984$9
Omeprazole81$863$11
Amlodipine Besylate66$688$10
Ultra-Fine Nano Pen Needle11$494$45
Fluconazole37$431$12
Tamsulosin28$394$14
Calcitriol42$360$9
Potassium Chloride11$270$25
Carvedilol20$257$13
Furosemide40$256$6
Labetalol11$255$23
Metoprolol28$226$8
Hydralazine11$197$18
Clonidine13$152$12
Pravastatin11$135$12
Pantoprazole11$128$12
Ciprofloxacin23$110$5
Lisinopril18$101$6
Atorvastatin12$86$7

2022: 33 drugs

Part D drugs prescribed in 2022
Cinacalcet66$56,606$858
Valganciclovir55$33,628$611
Tacrolimus173$29,627$171
Nulojix14$27,659$1,976
Mycophenolate Mofetil129$18,768$145
Eliquis21$12,670$603
Lokelma19$11,583$610
Mycophenolic Acid32$8,495$265
Humalog Kwikpen U-10015$4,451$297
Prednisone354$2,442$7
Entecavir31$1,883$61
Nifedipine Er20$1,584$79
Hydralazine24$649$27
Losartan71$583$8
Calcitriol30$579$19
Sulfamethoxazole-Trimethoprim85$573$7
Tamsulosin37$494$13
Amlodipine Besylate54$440$8
Omeprazole58$395$7
Carvedilol43$340$8
Furosemide64$294$5
Fluconazole26$227$9
Atorvastatin26$191$7
Cephalexin19$181$10
Metoprolol39$180$5
Pravastatin17$160$9
Pantoprazole17$120$7
Clonidine11$119$11
Famotidine14$113$8
Lisinopril22$81$4
Ciprofloxacin15$79$5
Glipizide15$71$5
Amiodarone11$41$4

2021: 38 drugs

Part D drugs prescribed in 2021
Tacrolimus212$56,692$267
Valganciclovir100$45,190$452
Lokelma42$34,588$824
Nulojix17$33,386$1,964
Cinacalcet39$27,417$703
Mycophenolic Acid49$22,204$453
Mycophenolate Mofetil105$18,541$177
Novolog Flexpen31$15,922$514
Lantus Solostar18$6,127$340
Lamivudine Hbv35$4,402$126
Humalog Kwikpen U-10020$3,265$163
Calcitriol36$2,903$81
Basaglar Kwikpen U-10011$2,898$263
Nifedipine Er42$2,080$50
Prednisone241$1,534$6
Dapsone20$1,296$65
Sulfamethoxazole-Trimethoprim128$951$7
Losartan89$819$9
Omeprazole86$759$9
Midodrine11$716$65
Ultra-Fine Nano Pen Needle11$673$61
Fluconazole42$600$14
Amlodipine Besylate72$530$7
Hydralazine22$461$21
Tamsulosin44$439$10
Entecavir12$332$28
Metoprolol46$300$7
Potassium Chloride17$227$13
Atorvastatin29$223$8
Carvedilol23$210$9
Furosemide37$158$4
Cephalexin14$149$11
Hydroxyzine13$147$11
Pantoprazole16$143$9
Pravastatin12$137$11
Famotidine13$131$10
Ciprofloxacin22$124$6
Lisinopril19$98$5

2020: 29 drugs

Part D drugs prescribed in 2020
Tacrolimus120$41,476$346
Cinacalcet47$38,213$813
Valganciclovir58$26,517$457
Mycophenolic Acid22$12,111$551
Mycophenolate Mofetil62$8,802$142
Lamivudine Hbv38$7,876$207
Januvia12$5,934$494
Basaglar Kwikpen U-10012$2,982$249
Lantus Solostar14$2,853$204
Nifedipine Er43$2,100$49
Cyclosporine Modified12$1,717$143
Ultra-Fine Nano Pen Needle11$1,297$118
Prednisone140$947$7
Flunisolide12$654$54
Omeprazole59$519$9
Sulfamethoxazole-Trimethoprim58$415$7
Losartan34$355$10
Amlodipine Besylate53$328$6
Tamsulosin21$292$14
Hydralazine15$284$19
Enalapril Maleate19$241$13
Metoprolol18$236$13
Furosemide35$210$6
Pantoprazole19$207$11
Fluconazole22$186$8
Atorvastatin20$182$9
Ciprofloxacin26$158$6
Glipizide19$136$7
Lisinopril24$118$5

2019: 9 drugs

Part D drugs prescribed in 2019
Tacrolimus18$5,970$332
Nifedipine Er41$1,449$35
Flunisolide14$762$54
Alcohol Pads14$668$48
Prednisone37$273$7
Tamsulosin22$231$11
Furosemide33$201$6
Famotidine11$131$12
Amlodipine Besylate28$98$4

2018: 14 drugs

Part D drugs prescribed in 2018
Eliquis11$6,361$578
Lantus Solostar12$2,748$229
Nifedipine Er42$2,145$51
Nateglinide19$1,133$60
Flunisolide13$950$73
Alcohol Pads11$551$50
Enalapril Maleate13$426$33
Tamsulosin33$418$13
Prednisone49$324$7
Metoprolol25$196$8
Atorvastatin14$161$12
Carvedilol23$134$6
Furosemide16$101$6
Amlodipine Besylate30$98$3

2017: 6 drugs

Part D drugs prescribed in 2017
Sensipar13$10,928$841
Esomeprazole Magnesium15$1,967$131
Valsartan13$249$19
Prednisone39$174$4
Amlodipine Besylate20$146$7
Furosemide15$80$5

2016: 4 drugs

Part D drugs prescribed in 2016
Sensipar12$8,543$712
Valsartan20$421$21
Warfarin16$96$6
Prednisone17$72$4

2015: 14 drugs

Part D drugs prescribed in 2015
Sensipar15$9,102$607
Valsartan13$582$45
Nifedipine Er12$464$39
Nifedical Xl12$411$34
Alcohol Pads11$245$22
Tamsulosin12$162$14
Glipizide Er11$106$10
Prednisone21$103$5
Finasteride12$99$8
Metoprolol15$93$6
Atorvastatin11$89$8
Simvastatin11$77$7
Amlodipine Besylate19$70$4
Furosemide13$32$2

2014: 20 drugs

Part D drugs prescribed in 2014
Sensipar15$8,787$586
Diovan30$4,715$157
Lantus Solostar11$3,530$321
Nexium11$2,649$241
Nifedical Xl12$686$57
Metoprolol19$530$28
Nifedipine Er11$486$44
Atorvastatin12$341$28
Easy Touch Pen Needle12$329$27
Gabapentin14$321$23
Calcitriol14$298$21
Clonidine23$288$13
Tamsulosin12$139$12
Amlodipine Besylate21$137$7
Clopidogrel18$130$7
Furosemide25$125$5
Prednisone14$85$6
Famotidine17$80$5
Atenolol17$64$4
Hydrochlorothiazide13$20$2

2013: 28 drugs

Part D drugs prescribed in 2013
Sensipar34$20,343$598
Cellcept12$17,600$1,467
Lantus18$5,314$295
Tacrolimus17$5,297$312
Lantus Solostar17$4,511$265
Nexium20$4,322$216
Diovan28$3,836$137
Advair Diskus11$3,822$347
Novolog Flexpen11$3,471$316
Nifedipine Er45$1,787$40
Metoprolol38$1,187$31
Clopidogrel30$1,112$37
Mycophenolate Mofetil21$943$45
Nifedical Xl14$830$59
Atorvastatin32$662$21
Omeprazole26$443$17
Calcitriol11$443$40
Novofine11$372$34
Tamsulosin21$337$16
Clonidine15$223$15
Amlodipine Besylate37$198$5
Enalapril Maleate22$183$8
Prednisone61$175$3
Famotidine24$169$7
Furosemide38$154$4
Metoprolol20$141$7
Atenolol24$133$6
Allopurinol14$75$5

Money from drug and device companies

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
SANOFI US SERVICES INC. · A Multi-Cohort, Randomized, Phase 2, Open-Label Study To Assess the Preliminary Efficacy, Safety, and Pharmacokinetics of Bivv020 for Prevention and Treatment of Antibody-Mediated Rejection in Adult Kidney Transplant Recipients. · 2025Their institution$63,061
SANOFI US SERVICES INC. · A Multi-Cohort, Randomized, Phase 2, Open-Label Study To Assess the Preliminary Efficacy, Safety, and Pharmacokinetics of Bivv020 for Prevention and Treatment of Antibody-Mediated Rejection in Adult Kidney Transplant Recipients. · 2024Their institution$24,626

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
82.3 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1104001718
Licence
CA C154027, NY 003757California C154027: Current · expires 2027-11-30
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RN0300X (207RN0300X); Student in a training program (390200000X)
Mailing address
400 Parnassus Ave, San Francisco, CA, 94143
NPI first listed
2008-01-02
NPI last updated
2020-12-08
NPI record certified
2020-12-08

This is when the NPI record was last certified, not a medical board exam.